GBBYF yields 5.25% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, GBBYF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GBBYF + PFE for your $10,000?
Goodbaby International Holdings Limited, an investment holding company, researches, designs, develops, manufactures, markets, and sells durable juvenile products in Europe, North America, Mainland China, and internationally. The company operates through four segments: Strollers and Accessories, Car Seats and Accessories, Non-Durable Products, and Others. It offers children's car safety seats, strollers, apparels and home textile products, feeding products, nursing and personal care products, cribs, bicycles and tricycles, and other children products. The company also provides safety belts, cloth sets, and car components for children; child cloth beds; bath chairs for children; stadium chairs; sports utilities, e-cars, and wooden products; and child carrying systems, pushchairs, high chairs, and other products for children, as well as maternity products. In addition, it offers IT services and a share service center; testing services for children's products, tools, and electronic products; and advisory services for the risk valuation of product quality. Further, the company is involved in the distribution and sale of car safety seats, infant strollers, and other parenting products; and wholesale and retail of children's products. It also operates flagship stores. The company provides its products under the Goodbaby, CYBEX, gb, Evenflo, RollPlay, CBX, Exer Saucer, Urbini, and Happy Dino brands. The company was founded in 1989 and is headquartered in Kunshan, the People's Republic of China.
Full GBBYF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.